George Church spinoff swallows a key manufacturing partner as it preps CRISPR-edited pig organs for animal testing

Amber Tong

Researching, cloning and breeding gene-edited pigs are core to eGenesis’ audacious mission to grow organs that can be xenotransplanted into humans. But perhaps unsurprisingly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

George Church spinoff swallows a key manufacturing partner as it preps CRISPR-edited pig organs for animal testing

Amber Tong

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

Trump blog: Judge extends nationwide block on NIH payment cuts

RFK Jr. readies review of childhood vaccine schedule after pledging not to

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

George Church spin­off swal­lows a key man­u­fac­tur­ing part­ner as it preps CRISPR-edit­ed pig or­gans for an­i­mal test­ing

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

George Church spinoff swallows a key manufacturing partner as it preps CRISPR-edited pig organs for animal testing